Haane Massarotti, MD
Colon & Rectal Surgery · Franklin, TNNPI 1518194083
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by THD America, Inc. at 37.5% of the total. 2023 is the largest year on record at $1,620, 6.3 times the $259 reported in 2019.
Across 45 payments — averaging $72.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- THD America, Inc.$1K
- Medtronic$725
- Axonics, Inc.$489
- Baxter Healthcare$127
- Conmed Corporation$125
- Takeda Pharmaceuticals U.S.A., Inc.$125
- plus $458 from 16 others
Across 1 payment — averaging $20,156 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acell, Inc.$20K
What the payments were for
- Consulting fees$72522%
- Speaking & faculty fees$1254%
- Travel & lodging$81425%
- Food & beverage$1,61349%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| THD America, Inc. | 12 | $1,228 |
| Medtronic | 1 | $725 |
| Axonics, Inc. | 9 | $489 |
| Baxter Healthcare | 2 | $127 |
| Conmed Corporation | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Intuitive Surgical | 2 | $98 |
| Boston Scientific | 1 | $77 |
| Stryker | 1 | $65 |
| Alcresta Therapeutics, Inc. | 3 | $33 |
| Innovation Technologies Inc | 1 | $24 |
| LSI Solutions Inc | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $18 |
| Lumendi LLC | 1 | $17 |
| Merck | 1 | $16 |
| Shire North American Group Inc | 1 | $14 |
| Smith+Nephew | 1 | $13 |
| Portola Pharmaceuticals, LLC | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Hollister Incorporated | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $11 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,277 in reported general payments places this provider in the 60th percentile of 31 colon & rectal surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $145 |
| Oxycodone Hcl | 50 | $79 |
| Gabapentin | 14 | $39 |
| Ibuprofen | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Franklin
- Aimal KhanNashville$35K
- Sree SuryadevaraNashville$24K
- Justin MonroeMemphis$14K
- William HarbNashville$8K
- Shannon McChesneyNashville$7K
- Terah IsaacsonCookeville$7K
- Gregory LowKnoxville$6K
- Molly FordNashville$6K
- Christopher MascarenhasNashville$6K
- Jay YoungKnoxville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.